Hospital dos Servidores do Estado - Rio de Janeiro Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01210365
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Hospital dos Servidores do Estado

Active Ingredients

Drugs in Phase 4 Trials (1)

triamcinolone (kenalog) (1 trial)

Drugs in Phase 3 Trials (2)

amiloride (midamor) (1 trial)

furosemide (lasix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3